- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02911064
Expectations Regarding Mobility and Self-Care
Assessment of Expectations Regarding Mobility and Self-Care Between Physiatrists and Oncology Patients
Study Overview
Status
Intervention / Treatment
Detailed Description
If you agree to take part in this study, you will complete questionnaires before your inpatient rehabilitation and after you complete inpatient rehabilitation. The questionnaires will ask about how well you currently perform daily living activities, your expectation of how well you will perform daily living activities after you complete inpatient rehabilitation, your symptoms in the past 24 hours, and your physical, functional, social, and emotional well-being. These questionnaires should take about 15 minutes total to complete.
Information from your medical record (such as your age, gender, religion, cancer diagnosis, stage of cancer, and so on) will be collected.
Length of Study:
You participation on this study will be over after you complete the questionnaires.
This is an investigational study.
Up to 111 participants will take part in this study. All will be enrolled at MD Anderson.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Participants are willing and able to give written informed consent and to comply with all of the study visits and surveys
- Patients with any type of cancer admitted on the acute inpatient rehabilitation unit who can tolerate 3 hours of rehabilitation therapies per day
- Patients 18 years and older
- Patients must be able to understand, read, write, and speak English.
Exclusion Criteria:
- Patients who have delirium, severe symptom distress, or cognitive impairment.
- Patients who return to primary service prior to discharge from the acute inpatient rehabilitation unit.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Assessment Questionnaires
Questionnaires completed before and after inpatient rehabilitation.
Questionnaires ask about daily living activity performance, expectation of how well daily living activities will be performed after completion of inpatient rehabilitation, symptoms experienced in the past 24 hours, and physical, functional, social, and emotional well-being.
|
Questionnaires completed before and after inpatient rehabilitation.
Questionnaires ask about daily living activity performance, expectation of how well daily living activities will be performed after completion of inpatient rehabilitation, symptoms experienced in the past 24 hours, and physical, functional, social, and emotional well-being.
These questionnaires should take about 15 minutes total to complete.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Assessment of Participant and Physiatry Practitioner Expectations of Mobility and Activities of Daily Living After Acute Inpatient Rehabilitation Using Barthel Index
Time Frame: 3 days
|
3 days
|
Assessment of Participant and Physiatry Practitioner Expectations of Mobility and Activities of Daily Living After Acute Inpatient Rehabilitation Using Eastern Cooperative Oncology Group (ECOG) Performance Status Scales
Time Frame: 3 days
|
3 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ekta Gupta, MD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-0550
- NCI-2018-01760 (Other Identifier: NCI-CTRP-Clinical Trial Reporting Registry)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Neoplasms of Independent (Primary) Multiple Sites
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple Sites
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign Neoplasms | In Situ NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; BioMed Valley Discoveries, IncActive, not recruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasms of Mesothelial... and other conditionsUnited States
-
M.D. Anderson Cancer CenterEisai Inc.WithdrawnAdvanced Cancer | Malignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasms... and other conditions
-
M.D. Anderson Cancer CenterGateway for Cancer Research; James B. and Lois R. Archer Charitable FoundationRecruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Melanoma and Other Malignant Neoplasms of Skin | Malignant Neoplasm of Bone and Articular Cartilage | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasm of Male... and other conditionsUnited States
Clinical Trials on Questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
University Hospital, GrenobleUniversity Grenoble AlpsRecruitingChildhood Cancer | Adapted Physical ActivityFrance
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
Cliniques universitaires Saint-Luc- Université...Fonds National de la Recherche ScientifiqueNot yet recruitingAlcohol Use Disorder
-
Memorial Sloan Kettering Cancer CenterIcahn School of Medicine at Mount Sinai; Hackensack Meridian Health; Derald H...CompletedLeukemia | Multiple Myeloma | Non-Hodgkin's Lymphoma | Hodgkin's DiseaseUnited States